← FDA Drug Approvals (Drugs@FDA)
VANRAFIA
NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2025-04-02
Drug application
- FDA Application #
NDA219208- Application type
- New Drug Application
- Brand name
- VANRAFIA
- Generic name
- ATRASENTAN
- Active ingredients
- ATRASENTAN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVARTIS
- Manufacturer
- Novartis Pharmaceuticals Corporation
- First approval
- 2025-04-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown